RITE AID CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.05 USD | -31.13% |
|
-58.33% | -77.16% |
| 04-11 | First Motion for Exclusivity Period Extension Approved For Rite Aid Corporation | CI |
| 04-09 | Motion for Asset Sale Filed by Rite Aid Corporation | CI |
| Sales 2022 | 24.57B 1,967B | Sales 2023 | 24.09B 1,929B | Capitalization | 196M 15.7B |
|---|---|---|---|---|---|
| Net income 2022 | -538M -43.07B | Net income 2023 | -750M -60.04B | EV / Sales 2022 | 0.26 x |
| Net Debt 2022 | 5.89B 471B | Net Debt 2023 | 5.65B 453B | EV / Sales 2023 | 0.24 x |
| P/E ratio 2022 |
-0.92
x | P/E ratio 2023 |
-0.26
x | Employees | 47,000 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 97.31% |
More Fundamentals
* Assessed data
More news
Latest transcript on Rite Aid Corporation
More recommendations
More press releases
| 1 day | -31.13% | ||
| 1 week | -58.33% | ||
| Current month | -68.75% | ||
| 1 month | -54.55% | ||
| 3 months | -87.18% | ||
| 6 months | -77.27% | ||
| Current year | -77.16% |
1 week
0.04
0.16
1 month
0.040.20
Current year
0.000.51
1 year
0.003.16
3 years
0.0023.02
5 years
0.0032.48
10 years
0.00189.40
| Managers | Title | Age | Since |
|---|---|---|---|
Jeffrey Stein
CEO | Chief Executive Officer | 55 | 14/10/23 |
| Director of Finance/CFO | 53 | 31/12/99 | |
Elizabeth Burr
BRD | Director/Board Member | 62 | 09/04/19 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Arun Nayar
BRD | Director/Board Member | 73 | 29/10/18 |
Robert Knowling
BRD | Director/Board Member | 68 | 29/10/18 |
Bruce Bodaken
CHM | Chairman | 72 | 19/05/13 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 0.05 | -31.13% | 9,541 |
| 25/04/24 | 0.0726 | -51.21% | 18,570 |
| 24/04/24 | 0.1488 | +24.00% | 93,926 |
| 23/04/24 | 0.12 | -20.53% | 247,173 |
| 22/04/24 | 0.151 | +25.83% | 649,877 |
Delayed Quote OTC Markets, April 26, 2024 at 08:30 pm
More quotes
Rite Aid Corporation is a full-service pharmacy engaged in improving health outcomes. The Company meets customer needs with a range of solutions that offer convenience, including retail and delivery pharmacy, as well as services offered through its wholly owned subsidiaries Health Dialog Services Corporation (Health Dialog) and Bartell Drug Company (Bartell Drugs). Health Dialog provides healthcare coaching and disease management services via live online and phone health services. Regional chain Bartell Drugs supports the health and wellness needs in the Seattle area. Its Retail Pharmacy segmentâs primary business is the sale of prescription drugs and related consultation to its customers. Additionally, the Retail Pharmacy segment sells a full selection of health and beauty aids and personal care products, seasonal merchandise, and a large private brand product line. The Company operates more than 1,700 retail pharmacy locations across 16 states.
Sector
Drug Retailers
Calendar
19/06/2024
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -77.16% | 2.75M | |
| -12.86% | 8.57B | |
| +32.95% | 1.32B | |
| +6.76% | 419M | |
| +5.93% | 282M | |
| +10.56% | 224M | |
| -8.26% | 85.07M | |
| +20.94% | 59.57M |
- Stock Market
- Equities
- RADCQ Stock
